InsiderDirector
Jeffrey W. Albers Insider Trading Activity
Every SEC Form 4 transaction reported by Jeffrey W. Albers, sourced directly from SEC EDGAR and updated as new filings are accepted.
By Trabud Research Team · SEC Form 4 & insider trading data analysts
Last updated:
Quick Answer
Is Jeffrey W. Albers buying or selling?
Jeffrey W. Albers reported 0 open-market buys ($0) and 50 sells ($52.5M) across 50 Form 4 filings at 3 companies — a net selling position of $52.5M.
Source: SEC EDGAR Form 4
Key Statistics (as of Dec 8, 2025)
Total Form 4 filings
50
SEC EDGAR
Companies
3
Buys (0)
$0
Sells (50)
$52.5M
Insider sentiment
Net sellingNet insider flow of $52.5M in net selling, filed between May 9, 2018 – Dec 8, 2025.
Companies Jeffrey W. Albers files for
Recent Jeffrey W. Albers transactions
| Date | Ticker | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| Dec 8, 2025 | KYMR | Director | Sale | 5.0K | $448.8K |
| Oct 14, 2025 | KYMR | Director | Sale | 5.0K | $295.9K |
| Jun 3, 2025 | KYMR | Director | Sale | 6.3K | $311.1K |
| May 29, 2025 | BPMC | Director | Sale | 5.0K | $505.7K |
| Mar 17, 2025 | BPMC | Director | Sale | 5.8K | $512.0K |
| Mar 14, 2025 | BPMC | Director | Sale | 7.5K | $658.5K |
| Jan 24, 2025 | BPMC | Director | Sale | 15.2K | $1.7M |
| Jan 15, 2025 | BPMC | Director | Sale | 5.0K | $511.4K |
| Dec 20, 2024 | BPMC | Director | Sale | 15.0K | $1.3M |
| Nov 12, 2024 | BPMC | Director | Sale | 5.0K | $510.0K |
| Nov 8, 2024 | SYRE | Director | Sale | 6.7K | $246.3K |
| Oct 28, 2024 | SYRE | Director | Sale | 300 | $10.9K |
| Sep 11, 2024 | BPMC | Director | Sale | 19.7K | $1.7M |
| Aug 26, 2024 | KYMR | Director | Sale | 5.0K | $245.5K |
| Mar 27, 2024 | BPMC | Director | Sale | 11.0K | $1.0M |
| Mar 22, 2024 | BPMC | Director | Sale | 25.1K | $2.2M |
| Feb 21, 2024 | KYMR | Director | Sale | 5.0K | $195.3K |
| Jan 29, 2024 | BPMC | Director | Sale | 25.0K | $2.0M |
| Jan 24, 2024 | KYMR | Director | Sale | 10.0K | $300.5K |
| Dec 4, 2023 | BPMC | Director | Sale | 5.0K | $352.8K |
| Nov 3, 2023 | BPMC | Director | Sale | 10.0K | $602.0K |
| Sep 29, 2023 | BPMC | Director | Sale | 25.0K | $1.2M |
| Aug 28, 2023 | BPMC | Director | Sale | 25.0K | $1.2M |
| Mar 9, 2023 | BPMC | Director | Sale | 9.8K | $447.3K |
| Dec 8, 2022 | BPMC | Director | Sale | 20.0K | $1.0M |
Showing the 25 most recent filings of 50. Screen every filing.
Jeffrey W. Albers insider trading FAQ
Is Jeffrey W. Albers buying or selling?
Across 50 SEC Form 4 filings, Jeffrey W. Albers reported 0 open-market purchases totaling $0 and 50 sales totaling $52.5M — a net selling position of $52.5M.
Which companies does Jeffrey W. Albers file Form 4s for?
Jeffrey W. Albers has reported insider transactions at 3 companies, most often Blueprint Medicines Corp (BPMC), Kymera Therapeutics, Inc. (KYMR), Spyre Therapeutics, Inc. (SYRE).
How far back does Jeffrey W. Albers's filing history go?
Trabud holds Jeffrey W. Albers's SEC Form 4 filings from May 9, 2018 – Dec 8, 2025, sourced directly from SEC EDGAR.
Where does Trabud get Jeffrey W. Albers's insider trading data?
Directly from SEC EDGAR Form 4 filings. Every transaction on this page is a real filing accepted by the SEC, updated as new filings arrive.
Related Content
Track Jeffrey W. Albers and every other insider
Screen all SEC Form 4 filings by insider, company, transaction value, and role — or ask Trabud's AI agent in plain English.
Open the screener